I made yet another shares purchase today and this time round, the company picked was C&O Pharmaceutical Technology Limited [E92.SI].
The main reason why I bought this C&O is due to impressive to-come dividends. As anticipated by Philip Research, 4Q dividend could be at S$0.012 which makes the whole year dividend to be at S$0.08. If we were to use today's S$0.47/share, it would be 17%! This very healthy net cash comes after they sold Hong kong asset, which add to their EPS.
1 past dividend and 1 coming soon
Ex Date: 26 Aug 2010 SGD 0.028
Ex Date: 12 Jul 2010 SGD 0.005
Ex Date: 12 Jul 2010 SGD 0.035
This China-based drug maker's strong R&D capability provides springboard to launch new products, paving way for expansion in local and international markets. According to CIMB analyst, C&O is also an attractive partner to foreign drug companies looking to enter the China market.
Stay invested for the dividends remain my key investment strategy.
Subscribe to:
Post Comments (Atom)
Popular Posts
-
新加坡人口400万，亚洲人口4亿，全世界人口6亿。 但是，我一人可能就很有可能是世界最傻的了。我真是个不折不扣的大木头。真是受不了自己。
-
For anyone living in or visiting Singapore, mastering the public transport system is a rite of passage. While the MRT is efficient, the exte...
-
*********** Try to sleep now, close your eyes Soon the birds would stop singing Twinkling stars, are shining bright They'll be watch...
-
I got the below findings from Taipei , Hong Kong and Singapore and I thought I should share them with all of you. Taxi Fares In Taipei Tax...
-
The Consumers Association of Singapore (CASE) response on the planned 21% electricity tariff hike says it all. CASE advise Singaporeans to ...
No comments:
Post a Comment
Do provide your constructive comment. I appreciate that.